Viracta Therapeutics Inc. (VIRX)
undefined
undefined%
At close: undefined
0.20
-6.82%
After-hours Jan 03, 2025, 05:57 PM EST

Viracta Therapeutics Inc. Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for VIRX stock have an median target of 3, with a low estimate of 2 and a high estimate of 4. The median target predicts an increase of 1263.64% from the current stock price of 0.22.

Analyst Consensus: Buy
Target Low Average Median High
Price $2 $3 $3 $4
Change 809.09% 1263.64% 1263.64% 1718.18%

AI Analyst Report

RBC Capital maintains an Outperform rating on Vira... Unlock content with Pro Subscription

Updated Nov 14, 2024

Rating Jan 24Mar 24Apr 24May 24Aug 24Nov 24
Strong Buy 000000
Buy 112111
Hold 000010
Sell 000000
Strong Sell 000000
Total 1 1 2 1 2 1

Financial Forecast this Year

Revenue This Year
3.50M
from -
Increased by ∞B%
Revenue Next Year
19.36M
from 3.50M
Increased by 453.1%
EPS This Year
-0.61
from null
Increased by -∞B%
EPS Next Year
-0.36
from -0.61
Increased by 41.0%